Hologic reports Q3 adjusted EPS $1.08, consensus $1.05

Reports Q3 revenue $1.023B, consensus $1.01B. “We are pleased to have delivered revenue and non-GAAP earnings growth in the third quarter that exceeded our guidance ranges,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer. “And we made great progress toward returning to better top- and bottom-line growth in the fourth quarter, driven by the continued rebound of our Breast Health business and solid performances by our other divisions.”